The core of the innovation is what the researchers call an osmoregulatory stress transcriptional profiling chip, abbreviated OSTP. Built on the TaqMan quantitative PCR chemistry and deployed on the high-throughput OpenArray platform, the chip packages 28 individual gene expression assays into a compact format that can process many samples in parallel. Quantitative PCR, or qPCR, works by amplifying and measuring specific messenger RNA targets that have been reverse-transcribed into complementary DNA, providing a snapshot of how actively each gene is being transcribed in a given tissue at a given moment. Because transcriptional changes often precede overt physiological symptoms, this class of measurement offers a window into the earliest stages of an animal’s stress response, when intervention by hatchery managers or aquaculture producers could still change the outcome.

The 28 assays on the OSTP chip were not chosen at random. Twelve of them target genes directly involved in osmoregulation, the biochemical machinery that moves ions and water across cell membranes and maintains internal homeostasis in the face of external salinity change. Four assays track canonical stress response genes, the molecular alarm bells that fire when an animal perceives a threat to its physiological equilibrium. Five assays monitor immune function, reflecting the well-documented crosstalk between stress and immunity, in which prolonged stress hormones can suppress defensive pathways and leave fish vulnerable to disease. Four more assays cover growth and metabolism, capturing the energetic trade-offs that arise when an animal diverts resources toward survival and away from tissue building. The remaining three assays are endogenous controls, housekeeping genes whose expression is expected to remain stable so that researchers can normalize their measurements and distinguish true biological signal from technical noise.

One of the most significant hurdles in developing molecular tools for non-model organisms is that a single assay designed for one species often fails, or performs unpredictably, in a close relative. Salmonids present a special challenge in this regard because of their complex evolutionary history, which includes an ancient whole-genome duplication followed by ongoing rediploidization, meaning that duplicated genes can retain similar sequences while diverging in function. The research team therefore set out to develop and assess assays that would work not just in one model species but across eight salmonid species spanning four genera. This multispecies ambition is what distinguishes the OSTP chip from many earlier qPCR panels, which were typically validated in a single species such as rainbow trout or Atlantic salmon and then applied, often without rigorous testing, to others.

To evaluate the chip, the researchers used gill and liver tissues from all eight species. The choice of tissues is biologically meaningful: the gill is the primary interface between the fish and the surrounding water, and it hosts the ionocytes and epithelial transport machinery that bear the brunt of osmotic challenge, while the liver serves as a metabolic hub whose transcriptional activity reflects the systemic energetic cost of coping with stress. By running the same 28 assays on both tissues across all species, the team could ask two distinct questions. First, does the chip produce reliable, interpretable measurements in every species tested? Second, do the transcriptional patterns themselves differ between tissues and between species in ways that make biological sense?

The answer to both questions was yes, with important nuances. The results revealed both tissue-specific and species-specific transcriptional differences, which the authors interpret as evidence that while the underlying osmoregulatory toolkit is shared across salmonids, its deployment varies according to each species’ life history and ecological context. A species that spends more of its life at sea, for example, might maintain a different baseline of ion transporter expression than a more freshwater-oriented relative. These differences do not undermine the chip’s utility; rather, they underscore why a validated multispecies platform is valuable. Researchers can now compare stress responses across species using the same assays, under the same chemistry, with the same normalization strategy, rather than stitching together results from incompatible single-species protocols.

Validation of a molecular tool requires more than cross-species compatibility; it requires demonstration that the tool detects a real biological signal under controlled conditions. For this purpose, the team turned to Chinook salmon, the largest of the Pacific salmonids and a species of major importance to fisheries and aquaculture in the Pacific Northwest. They subjected fish to a 24-hour saltwater challenge, a standard experimental manipulation in which fish acclimated to freshwater are transferred to seawater, forcing their osmoregulatory systems to respond acutely. Control fish remained in freshwater. After the challenge period, gill and liver samples from both groups were profiled on the OSTP chip, and the results confirmed that the platform could detect the acute molecular signatures induced by osmotic stress. Genes involved in ion transport and stress response shifted their transcriptional output in challenged fish relative to controls, exactly the pattern the chip was designed to reveal.

The implications of this work extend well beyond the laboratory. In commercial aquaculture, salmonids are routinely moved between salinity regimes, whether during smoltification when juvenile fish transition toward seawater readiness, during transport between freshwater and marine grow-out sites, or in response to changing water quality conditions. Each of these transitions carries a risk of osmotic stress that is currently assessed through indirect indicators such as growth rates, feed conversion, or mortality counts, all of which lag behind the actual physiological event. A chip-based transcriptional assay could, in principle, allow producers to sample a subset of fish, profile their stress gene expression within hours, and adjust husbandry practices, such as the timing of seawater transfer or the management of handling and crowding, before stress translates into losses. The authors specifically highlight this application, noting that the OSTP chip will be useful for aquaculture practices by fostering better husbandry.

Conservation biology stands to benefit as well. Hatchery programs that rear salmonids for release into wild populations face persistent questions about whether their fish are physiologically prepared for the environments they will encounter. A standardized stress-profiling tool could help hatchery managers evaluate the physiological condition of their stocks, compare rearing protocols, and even assess how wild-caught broodstock respond to captivity. Because the chip works across multiple species, the same platform could serve programs targeting Chinook salmon, coho, steelhead, and other salmonids without requiring species-specific assay development each time, a substantial saving of time and resources for laboratories with limited budgets.

More broadly, the study contributes to a growing movement in environmental physiology toward standardized, high-throughput molecular monitoring of non-model organisms. As climate change alters the salinity profiles of coastal waters, estuaries, and rivers, and as aquaculture expands into new environments, the ability to measure stress at the molecular level across many species becomes increasingly valuable for both research and management. The OSTP chip is a concrete step in that direction: a modest panel of 28 carefully chosen genes, validated across four genera, and demonstrated to detect acute osmotic stress in a real experimental challenge. It is not a complete picture of the salmonid stress response, and the authors are careful to frame it as a tool with considerable utility rather than a definitive diagnostic. But as a foundation for future studies of how salmonid fishes respond to environmental stress, and as a practical instrument for the people who raise and conserve these fish, the chip fills a genuine gap. The research, published in PLOS One, offers the aquaculture and conservation communities a shared molecular vocabulary for talking about stress, one that is grounded in the transcriptional activity of the genes that matter most when a fish meets the sea.

Subject of Research: Development of a multispecies qPCR gene expression chip for detecting osmoregulatory stress in salmonid fishes

Article Title: Gene transcriptional profiling of osmoregulatory stress response in salmonids: Development and assessment of high-throughput multispecies assays

Article References: Tugui, N., Islam, S. S., & Heath, D. D. (2026). Gene transcriptional profiling of osmoregulatory stress response in salmonids: Development and assessment of high-throughput multispecies assays. PLOS One, 21(10), e0360513. https://doi.org/10.1371/journal.pone.0360513

Image Credits: AI Generated

DOI: 10.1371/journal.pone.0360513

Keywords: salmonids, osmoregulation, qPCR, OpenArray, gene expression, stress response, aquaculture, Chinook salmon, saltwater challenge, gill tissue, conservation, transcriptional profiling

The research, led by Habib Francis of the Sydney Clinical Trials Centre at The University of Sydney together with colleagues across Australia, Hong Kong and India, drew on plasma samples from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial, a landmark randomised controlled trial of nearly 10,000 adults with type 2 diabetes. Because the samples came from a large, well-characterised clinical cohort, the team could interrogate the behaviour of 18 S rRNA across hundreds of real biobanked specimens rather than a handful of laboratory controls. In total, 789 plasma RNA samples analysed across 17 separate OpenArray runs formed the backbone of the stability assessment, giving the study a statistical weight that most reference-gene validations never approach.

The technical challenge the authors set out to resolve is a genuine worry in multiplexed qPCR. Microfluidic OpenArray plates pack thousands of nanolitre-scale reactions onto a single plate, and the tiny input of plasma RNA, which is naturally dilute and dominated by fragmented extracellular species, usually forces a pre-amplification step. During those 14 cycles of targeted pre-amplification, all the primer pairs in the pool compete for the same enzymes, nucleotides and reaction space. Highly abundant transcripts such as 18 S rRNA, which can be present at levels orders of magnitude above the messenger RNA targets of interest, could in theory monopolise shared reagents and quietly suppress the amplification of scarcer targets. If that happened, Ct values would shift in ways that no amount of normalisation could correct, corrupting every downstream comparison.

To test this directly, the researchers ran a paired experiment on 23 plasma samples. Each sample was pre-amplified twice, once with a primer pool containing the 18 S rRNA assay and once with an otherwise equivalent pool lacking it. The team then measured four representative target genes, ACTG1, ACTB, CLU and PFN1, under both conditions and compared the raw cycle threshold values sample by sample. Because not every gene was detectable in every sample, the effective sample sizes ranged from eight to seventeen per assay, a limitation the authors acknowledge candidly. Even so, the paired design is the cleanest possible way to isolate the effect of a single primer from all other sources of variation.

The verdict was reassuring. Median paired Ct differences between the two pre-amplification conditions ranged from just 0.07 to 0.52 cycles, and none of the four targets showed a statistically significant shift, with all p-values exceeding 0.05. Bland–Altman analysis, which plots the difference between paired measurements against their average, confirmed the picture: the mean bias across all four genes combined was a negligible −0.18 Ct, and the data points for each gene were distributed similarly, mostly falling within the 95 percent limits of agreement. In plain terms, adding 18 S rRNA to the pre-amplification pool did not measurably distort the amplification of the co-amplified messenger RNA targets under the conditions tested. The feared competition effect, at least in this workflow, did not materialise.

The stability data were equally encouraging. Across the 789 samples and 17 runs, 18 S rRNA was consistently detectable, with a median Ct of 14.5 and an interquartile range of 13.4 to 16.3. The distribution of Ct values was unimodal, clustering tightly around the median without the bimodality or systematic shifts that would hint at batch effects or hidden technical artefacts. Inter-run variability was low, with a coefficient of variation of just 3.9 percent and no significant differences between runs. Notably, these results were obtained using archived plasma samples that had endured three freeze–thaw cycles, conditions typical of longitudinal clinical biobanking, suggesting that 18 S rRNA detection remains technically robust even when samples have been handled the way real-world studies demand.

The study also tackled a practical problem that haunts long-running biomarker projects: what happens when a primer pool runs out? The FIELD analyses had relied on an archived pre-amplification pool containing the 18 S rRNA assay, stored unopened at −80 °C for more than five years. The researchers compared 18 S rRNA Ct values in 774 paired plasma samples amplified with either that archived pool or a newly manufactured one. Amplification succeeded under both conditions, but the new pool produced slightly lower Ct values, a statistically significant shift with a mean bias of 0.53 Ct. More concerning was the spread: the standard deviation of paired differences was 3.82 Ct, with 95 percent limits of agreement stretching from −6.95 to 8.01 Ct, and variability appeared to widen at higher average Ct values, where template abundance is lowest.

That combination of a small average bias and wide individual-level variability carries an important lesson for anyone managing longitudinal studies. The authors conclude that data generated with archived and new primer pools remain broadly comparable at the group level, but the two pools should not be treated as directly interchangeable for individual paired measurements. They recommend practical safeguards: keeping detailed records of primer sequences, concentrations and manufacturing lots; running bridging experiments on a representative subset of samples whenever a pool must be replaced; and using paired comparisons with Bland–Altman analysis to quantify any systematic bias before transitioning. Where the bias is small and consistent, calibration may suffice; where variability is large, reanalysis with a common pool or an alternative validated assay may be the only defensible option.

The authors are careful to frame what this study does and does not prove. Their findings establish the technical performance of 18 S rRNA within plasma-based OpenArray workflows, not its biological stability across disease states or experimental conditions, and they cannot be assumed to extend to other sample types, platforms or pre-amplification chemistries. Plasma is a peculiar analytical matrix, rich in fragmented extracellular RNA and poor in total messenger RNA, and pre-analytical variables such as blood collection tube type can reshape extracellular RNA profiles entirely. Still, by combining large-scale stability assessment, paired technical comparisons and a real-world test of reagent longevity, the study offers a template for validating endogenous controls in any high-throughput qPCR setting, and it gives biomarker researchers working with scarce clinical plasma a solid reason to trust one of molecular biology’s oldest internal controls.

Subject of Research: Validation of 18 S rRNA as an endogenous control gene in high-throughput plasma RNA qPCR workflows

Article Title: Evaluation of 18 S rRNA as an endogenous control in OpenArray® plasma RNA qPCR workflows

Article References: Francis, H., Januszewski, A. S., Mangani, A., Ema, F. K., Hardikar, A. A., Joglekar, M. V., Huang, M. L., Sullivan, D. R., Ma, R. C., Galande, S., Gebski, V., Simes, R. J., Jenkins, A. J., Molloy, M. P., & Keech, A. C. (2026). Evaluation of 18 S rRNA as an endogenous control in OpenArray® plasma RNA qPCR workflows. Molecular Biology Reports, 53(1), Article 1641. https://doi.org/10.1007/s11033-026-12820-9

Image Credits: AI Generated

DOI: 10.1007/s11033-026-12820-9

Keywords: qPCR, 18S rRNA, OpenArray, plasma RNA, endogenous control, pre-amplification, reference gene, Bland-Altman analysis, FIELD trial, biomarkers, gene expression normalisation, technical validation